Authors

Navigating Access and Reimbursement Through Uncertainty

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.

Working with the Middle

How pharma can productively coexist with PBMs—and still lower drug costs faster.

Why Your EHR Messaging Must Be Real-Time

This first-party approach to data-driven messaging can ensure timely, compliant, and personalized engagement with healthcare providers at the point of care.

The Prominence of Pharmacy Deserts

How chain and local closures are impacting healthcare access.

Quality and Compliance in the Pharmaceutical Industry: Navigating a Transformed Landscape

Rising recalls, tighter FDA enforcement, global supply chain dependencies, and rapid technology shifts are reshaping pharmaceutical quality and compliance—forcing manufacturers to rethink oversight, resilience, and continuous improvement across operations.

Why Direct-to-Patient Is the Pharma Industry’s Next Power Move

How direct-to-patient programming can transform the prescription journey for patients and manufacturers alike.

Your Guide to Outsourcing Critical Sample Management

Discover how to evaluate the true costs and considerations of internal vs. outsourced sample storage.

Addressing Polypharmacy Challenges in Europe with Real World Evidence

A multi-national study reveals over half of older adults in several European countries are prescribed five or more medications—spotlighting the urgent need for better data-driven prescribing strategies.

How DSCSA Compliance Is Unlocking Recall Efficiency

In the final part of his Pharma Commerce video interview, Dan Walles, VP & GM, traceability and compliance solutions, TraceLink, notes that while DSCSA was designed for compliance, its first major business value is enabling targeted recalls.

HDA 2025 Traceability Seminar: DSCSA Compliance Ushers in a More Secure and Transparent Pharma Supply Chain

Kala Shankle, JD, HDA’s vice president of regulatory affairs, shares that as DSCSA traceability requirements take full effect, distributors and trading partners are preparing for long-term gains in supply chain security, recall efficiency, and counterfeit prevention.

Omnichannel, Evolved: Redefining the Model for Modern Pharma Marketing

Pharma must align data, personalization, and cross-functional orchestration to deliver human-centered experiences that connect with patients, HCPs, and caregivers alike.

Building Agility and Adaptability Into Pharma Operations

Why driving results from such strategies—amid industry disruption—will be critical to success.

Pharma Industry Uncertainty in Wake of On/Off Greenland Tariffs

Even the threat of Greenland-related tariffs rattled drug supply chains and uncovered industry vulnerabilities to instability.

Congress Revives Push to Digitize Prescription Information

New bipartisan legislation would give the FDA authority to modernize prescribing information, reducing waste while improving accuracy and patient care.

2025 Pharma Forecast: Four Pivotal Trends Revolutionizing Market Access Strategies

How AI Control Towers and Digital Twins Can Restore Pharmaceutical Profit Margins

AI-powered control towers and digital twins are emerging as essential tools to prevent costly supply chain failures and restore operational reliability.

Building Agility and Adaptability Into Pharma Operations

Why driving results from such strategies—amid industry disruption—will be critical to success.

How AI-Powered Precision Is Reshaping Medical Affairs

Artificial intelligence is fundamentally transforming medical affairs from a reactive function into a strategic partner.

Trade & Channel Strategies 2025: Curatio's Priorities for Next Year

Cheryl Allen, BS Pharm, MBA, founding partner, highlights the coming year's focus on navigating an evolving regulatory landscape, while leveraging technology to track the pharmaceutical pipeline, assess analogs, and modernize distribution strategies.

Beyond the Brand Team: Why Every Employee Needs to Be Part of the Journey

Engaging the full workforce—from HR to R&D—can elevate launch outcomes, build trust, and create long-term brand ambassadors.

Forecasting the 2025 Healthcare Logistics Space

How will supply chains in the space continue to develop?

How Smart Packaging and Emerging AI Tools Are Shaping the Future of Cold Chain Integrity

In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’s CEO, and Mark Sawicki, PhD, Cryoport Systems’ president and CEO, explain how embedded product intelligence—paired with cautious, strategic adoption of AI—is redefining pharmaceutical cold chain reliability and supply-chain decision-making.

Why AI Advances in CGT Require Getting Data Right

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program

Point of Care Lifts Reps Efforts

Point of Care and PatientPoint can improve the impact that your Pharma Reps are already having.

From Data Overload to Intelligent Commercialization: How Pharma Can Turn Connection Into Competitive Advantage

When intelligence flows across clinical, access, and engagement channels, commercialization shifts from reactive to predictive, giving teams the real-time edge to win in a fast-moving market.

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead

Advice for pharma distributors and dispensers on what they should do now in order to solidify a secure supply chain.